Rating
Buy
Price target
$275
Previous
$225
Implied upside
+42%

Wedbush analyst Daniel Ives raised the price target on Oracle (NYSE: ORCL) to $275.00 (from $225.00) while maintaining an Outperform rating.

“We are raising our price target on Oracle to $275 from $225 and maintaining our OUTPERFORM rating as we gain incremental confidence based on our checks in the company’s strategic positioning within the AI infrastructure landscape.

Our view that the Oracle story is being misunderstood by the market remains intact, with investors placing too much emphasis on the near-term optics of its heavy, contract-backed capex cycle and too little emphasis on the underlying demand visibility supporting that investment.

We are becoming incrementally comfortable with the OpenAI relationship and more constructive on the broader data center story as, in our view, the fears surrounding Oracle remain overdone, and the company is increasingly positioned to be an AI winner on the global stage.

Oracle is building durable positioning in the next major phase of the AI revolution, where infrastructure, performance, and access to data will matter more than broad narrative enthusiasm.

We believe ORCL is emerging as one of the few companies that can support the most demanding AI workloads at scale.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.